Hyperlipidemia
📧 Sign up to get email alerts when something new happens for Hyperlipidemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2009-03-20Clinical Trial Update: Efficacy and Adverse Effect of Simvastatin Compare to Rosuvastatin in Systemic Lupus Erythematosus (SLE) Patients With Corticosteroid Therapy and High Low-Density Lipoprotein (LDL) Cholesterol Level [Phase 4]
Phase 4 trial comparing simvastatin and rosuvastatin in systemic lupus erythematosus patients on corticosteroids with high LDL cholesterol, …
-
CLINICAL_TRIALS trial_result · 2009-01-28Clinical Trial Update: Cross-Over Multicentre Study in Adolescents [NA]
A completed cross-over multicentre clinical trial in adolescents investigating overweight/obesity and hyperlipidemia.
-
CLINICAL_TRIALS trial_result · 2009-01-21Clinical Trial Update: The Effect of Altering Colonic Microflora After Fiber (FOS) Consumption [Phase 2]
Phase 2 clinical trial update evaluating the effect of altering colonic microflora after fiber (FOS) consumption; the study is completed.
-
CLINICAL_TRIALS trial_result · 2009-01-21Clinical Trial Update: Low Carbohydrate Diet Compared to Calorie and Fat Restricted Diet in Patients With Obesity and Type II Diabetes [Phase 3]
Phase 3 clinical trial comparing a low-carbohydrate diet to a calorie- and fat-restricted diet in adults with obesity and type 2 diabetes; t…
-
CLINICAL_TRIALS research · 2009-01-14Clinical Trial Update: The Epidemiology of Aortic Diameter in China
An update on a Zhejiang University-sponsored study examining the epidemiology of aortic diameter in China, including associations with vascu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2009-01-08FDA Approved: VYTORIN — Supplemental Application (Organon LLC)
FDA approved a supplemental application for VYTORIN (ezetimibe/simvastatin) submitted by Organon LLC.
-
CLINICAL_TRIALS trial_result · 2009-01-05Clinical Trial Update: The Effects of Atorvastatin on Vulnerable Plaques in Untreated Dyslipidemic Patients. [NA]
A completed trial evaluating the effects of atorvastatin on vulnerable atherosclerotic plaques in patients with hyperlipidemia.
-
FDA approval · 2008-12-15FDA Approved: FENOFIBRIC ACID — Original Application (Amneal Pharmaceuticals of New York LLC)
FDA approved fenofibric acid under an Original Application by Amneal Pharmaceuticals of New York LLC.
-
FDA approval · 2008-12-12FDA Approved: LIPOFEN — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Lipofen (fenofibrate) filed by ANI Pharmaceuticals, Inc., authorizing an update to the produ…
-
CLINICAL_TRIALS trial_result · 2008-11-26Clinical Trial Update: Pharmacy Interventions to Improve Chronic Disease Medication Refill [Phase 3]
Phase 3 clinical trial evaluating pharmacy interventions to improve chronic disease medication refills has completed.
-
FDA label_change · 2008-11-18FDA Approved: SIMVASTATIN — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application for simvastatin by Lupin Pharmaceuticals, likely involving labeling changes. This represents a suppl…
-
FDA approval · 2008-11-06FDA Approved: CRESTOR — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for CRESTOR (rosuvastatin) from AstraZeneca Pharmaceuticals LP. The approval updates the labeling to…
-
CLINICAL_TRIALS trial_result · 2008-10-23Clinical Trial Update: Preventing Heart Disease in Underserved Patients [NA]
A completed clinical trial update from Temple University describing a study aimed at preventing heart disease in underserved patients with h…
-
CLINICAL_TRIALS trial_result · 2008-09-17Clinical Trial Update: Ezetrol Post-Marketing Study [Phase 4]
Phase 4 post-marketing study of Ezetrol (ezetimibe) for hyperlipidemia has completed.
-
CLINICAL_TRIALS trial_result · 2008-09-09Clinical Trial Update: Efficacy and Safety of Geneferm Nattokinase [NA]
A completed clinical trial evaluating the efficacy and safety of Geneferm Nattokinase for hyperlipidemia.
-
CLINICAL_TRIALS research · 2008-07-29Clinical Trial Update: Standard Process 21 Day Purification Program Project [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial titled 'Standard Process 21 Day Purification Program' sponsored by Logan College of Chiropractic is investi…
-
CLINICAL_TRIALS trial_result · 2008-06-27Clinical Trial Update: Safety of a Hypolipidemic Agent in Healthy Normal Volunteers [Phase 1]
Phase 1 safety evaluation of a hypolipidemic agent in healthy volunteers has been completed. The study relates to hyperlipidemia and reports…
-
CLINICAL_TRIALS research · 2008-06-19Clinical Trial Update: Survey of Thai-Muslim Health Status
This document reports the completion of a Mahidol University survey studying health status among Thai-Muslim populations, focusing on diabet…
-
FDA approval · 2008-06-16FDA Approved: PRAVASTATIN SODIUM — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental ANDA for a generic pravastatin sodium product, authorizing marketing of the generic statin.
-
FDA approval · 2008-06-13FDA Approved: VYTORIN — Supplemental Application (Organon LLC)
FDA approved a supplemental application for VYTORIN (ezetimibe and simvastatin) from Organon LLC.
-
CLINICAL_TRIALS trial_result · 2008-06-09Clinical Trial Update: Phase 4 Study in Secondary Hypothyroidism: Body Weight Adapted Thyroxin Treatment and Triiodothyronine Supplementation [Phase 4]
Phase 4 clinical trial update evaluating body weight–adjusted thyroxine therapy with triiodothyronine supplementation in secondary hypothyro…
-
FDA approval · 2008-06-05FDA Approved: ZETIA — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for Zetia (ezetimibe) submitted by Organon LLC to update/expand aspects of its labeling.
-
FDA approval · 2008-06-03FDA Approved: FENOFIBRATE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' supplemental application for fenofibrate.
-
CLINICAL_TRIALS trial_result · 2008-06-03Clinical Trial Update: Efficacy and Safety Study of JTT-705 in Combination With Pravastatin 40 mg in Patients With Type II Hyperlipidemia [Phase 2]
Phase 2 trial evaluating the combination of JTT-705 and pravastatin 40 mg for Type II hyperlipidemia has completed, reporting on efficacy an…
-
FDA approval · 2008-05-30FDA Approved: WELCHOL — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Welchol (colesevelam hydrochloride) submitted by Cosette Pharmaceuticals, Inc., indicating a…